Irish patients not getting access to new medicines quickly enough says IPHA

The pharmaceutical industry claims that Irish patients are not getting access to new medicines quickly enough.

The Irish Pharmaceutical Healthcare Association says Ireland has the worst record in Europe when it comes to adopting new drugs.

The IPHA is discussing the issue at its annual conference today in Dublin.

Phillip Hannon from the IPHA says the method for deciding which drugs will be funded through by the HSE is too slow.

He said: "It is the processes that we have in terms of the reimbursement periods, the processs are wrong and I think need to be looked at.

"The minister himself said on the record in the Dail that the reimbursement system is broken."


Related Articles

World needs to reduce red meat and sugar consumption by half to safeguard planet

Gynaecologists claim free smear tests have put women’s lives in danger

Review of nurses' pay should be immediately set up to prevent national strike - opposition parties

Paediatric board accused of ‘failing catastrophically’ in children's hospital overspend

More in this Section

More Leaving Cert students choose higher level since grading reform, but performance levels drop

No-deal Brexit would be costly; Key projects may be put in jeopardy

Children’s hospital board ‘had no grasp of actual costs’

We have to get real on hard border, says garda


Lifestyle

Read an excerpt of 'My Coney Island Baby' below

Bernard O'Shea on hitting the road with old pal Karl Spain

Learning Points: My wife is having a baby and I’m stressed at work

Your guide to luxury - but affordable - spa experiences

More From The Irish Examiner